Cart
sales@molnova.com
ROC-325
CAS No. 1859141-26-6
ROC-325( ROC 325 | ROC325 )
Catalog No. M12869 CAS No. 1859141-26-6
ROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 74 | In Stock |
|
| 25MG | 157 | In Stock |
|
| 50MG | 246 | In Stock |
|
| 100MG | 384 | In Stock |
|
| 200MG | 548 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameROC-325
-
NoteResearch use only, not for human use.
-
Brief DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
-
DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy; exhibits superior in vitro anticancer effects compared with the existing autophagy inhibitor hydroxychloroquine (HCQ) in different cancer cell lines, including accumulation of autophagosomes with undegraded cargo, lysosomal deacidification, p62 stabilization, and disruption of autophagic flux; antagonizes RCC growth and survival in an ATG5/7-dependent manner, induces apoptosis and exhibited favorable selectivity; significantly more effective at inhibiting tumor progression than HCQ, and inhibited autophagy in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsROC 325 | ROC325
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1859141-26-6
-
Formula Weight503.061
-
Molecular FormulaC28H27ClN4OS
-
Purity>98% (HPLC)
-
SolubilityDMSO : 32 mg/mL 63.61 mM; H2O : < 0.1 mg/mL
-
SMILESO=C1C2=C(C(C)=CC=C2NCCN(C)CCNC3=C(C=CC(Cl)=C4)C4=NC=C3)SC5=CC=CC=C51
-
Chemical Name1-((2-((2-((7-chloroquinolin-4-yl)amino)ethyl)(methyl)amino)ethyl)amino)-4-methyl-9H-thioxanthen-9-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carew JS, et al. Clin Cancer Res. 2017 Jun 1;23(11):2869-2879.
2. Carew JS, et al. Autophagy. 2017 Apr 3;13(4):765-766.
molnova catalog
related products
-
ARN-5187
A novel lysosomotropic REV-ERB ligand that has a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy.
-
Sulfanilamide
Sulfanilamide is a competitive inhibitor for bacterial enzyme?dihydropteroate synthetase?with?IC50?of 320 μM.
-
XST-14
XST-14 is a competitive and specific inhibitor of ULK1 (IC50: 26.6 nM).XST-14 blocks autophagy by inhibiting the phosphorylation of ULK1 downstream substrates.XST-14 induces apoptosis and inhibits the growth of HCC cells.
